Stimulating Research | ASGCT - American Society of Gene & Cell Therapy |

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head>  <script type="text/javascript">(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-NFW5DS9');</script>   <script type="text/javascript"> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://cdn.informz.net/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script>  <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0" /> <link href="/BlueKey/pe_assets/build/styles.css" rel="stylesheet" /> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" <meta name="twitter:creator" content="@ASGCTherapy" <meta name="twitter:title" content="Stimulating Research" <meta name="twitter:description" content="There are a variety of required steps in the research and development of any new therapy, including a gene therapy, along with a variety of important resources that are needed as well." <meta name="twitter:image" content="~/attachment.aspx" <meta name="description" content="There are a variety of required steps in the research and development of any new therapy, including a gene therapy, along with a variety of important resources that are needed as well." /> <meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon" /> <title> Stimulating Research | ASGCT - American Society of Gene & Cell Therapy | </title></head> <body class="LTR IE IE7 ENUS ContentBody">  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <form method="post" action="/patient-journey/stimulating-research" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="l4KSfsX5vlklxrIRhB43DR0Q9RB15PJJK9X1NHMObTF6A/dW0LhfP6U1U8qrI3vt3UcaWhT8VFgghE31UFN/4p7N3hE=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="AD1448C3" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAMhGfcy1FkuHVS47Lw0/j/zDMN6QAizBz4KoPbUd79oAZD1NQdfl/cWuar5Vh7dGPS3jV3wFqsnfMqLUstrtpEY22ArtQ==" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <header class="c-header"> <a href="#content" class="show-on-focus">Skip to main content</a> <div class="c-header-utilities"> <div class="container"> <div class="columns is-vcentered"> <div class="column"> <a href="https://asgct.org" class="is-external">ASGCT.org</a> </div> <div class="column is-half"> <a href="/"> <div class="c-header-images"> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /> </div> <div class="c-header-image"> <img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /> </div> </div> </a> </div>  <div class="column"> <div class="c-header-search"> <div class="c-header-search-wrap"> <input name="keyword" type="text" id="searchtext" placeholder="Search" aria-required="false" /> <label for="searchtext" class="is-sr-only">Keyword search</label> <button type="button" data-encode="searchtext" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> </div> </div> </div> </div> <div class="c-header-utilities-mobile"> <div class="c-header-images"> <div class="c-header-image"> <a href="https://asgct.org" class="is-external"><img src="/PatientEducation/media/PatientEducation/ASGCT_Web_Horz_Navy.png?ext=.png" alt="" /></a> </div> <div class="c-header-image"> <a href="/"><img src="/PatientEducation/media/PatientEducation/temp-pe-logo.png?ext=.png" alt="Patient Education Logo" /></a> </div> </div> <button class="c-nav-toggle" type="button" aria-controls="c-nav-main" aria-expanded="false" data-togglevisibility="data-togglevisibility"> <p class="is-sr-only">Open Navigation</p> <p class="is-sr-only" aria-hidden="true">Close Navigation</p> <span class="c-nav-toggle-menu"></span> </button> </div> <div id="ctl00_plcMain_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p id="ctl00_plcMain_bkSiteHeader_pBanner"><b><a href="https://patienteducation.asgct.org/newsletter/subscribe-to-the-patient-press">Subscribe today to ASGCT's patient-centered newsletter, The Patient Press!</a></b></p> </div> </div> </div> <nav class="c-nav-main" id="c-nav-main" aria-hidden="true"> <div class="container"> <div class="c-header-search is-hidden-desktop"> <div class="c-header-search-wrap"> <input name="" type="text" id="global-search" placeholder="Search" aria-required="false" /> <label for="global-search" class="is-sr-only">Keyword search</label> <button type="button" data-encode="global-search" data-path="/search-results" data-query="searchtext"> <span class="is-sr-only">Search</span> <span class="c-search-icon"></span> </button> </div> </div> <ul> <li> <a href="/gene-therapy-101">Gene & Cell Therapy 101</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/cell-therapy-basics">Cell Therapy Basics</a> </li> <li> <a href="/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a> </li> <li> <a href="/gene-therapy-101/gene-editing">Gene Editing</a> </li> <li> <a href="/gene-therapy-101/clinical-trials">Clinical Trials</a> </li> <li> <a href="/gene-therapy-101/vectors-101">Vectors 101</a> </li> <li> <a href="/gene-therapy-101/glossary">Glossary</a> </li> <li> <a href="/gene-therapy-101/covid19-vaccines">COVID-19</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/disease-treatments">Condition Treatments</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/disease-treatments/fda-approved-cell-gene-therapy-products">FDA-Approved Cell & Gene Therapy Products</a> </li> <li> <a href="/disease-treatments/batten">Batten Disease</a> </li> <li> <a href="/disease-treatments/blood-disorders">Beta Thalassemia & Other Blood Disorders</a> </li> <li> <a href="/disease-treatments/leukodystrophy">CALD and MLD</a> </li> <li> <a href="/disease-treatments/car-t-basics">CAR-T Basics</a> </li> <li> <a href="/disease-treatments/fabry">Fabry Disease</a> </li> <li> <a href="/disease-treatments/gaucher-disease">Gaucher Disease</a> </li> <li> <a href="/disease-treatments/gm1-gangliosidosis">GM1 Gangliosidosis</a> </li> <li> <a href="/disease-treatments/gm2-tay-sachs-sandhoff">Tay-Sachs and Sandhoff Disease</a> </li> <li> <a href="/disease-treatments/hemophilia">Hemophilia</a> </li> <li> <a href="/disease-treatments/huntingtons-disease">Huntington's Disease</a> </li> <li> <a href="/disease-treatments/inherited-retinal-diseases">Inherited Retinal Diseases</a> </li> <li> <a href="/disease-treatments/mps">Mucopolysaccharidoses (MPS)</a> </li> <li> <a href="/disease-treatments/muscular-dystrophy">Muscular Dystrophy</a> </li> <li> <a href="/disease-treatments/pompe-disease">Pompe Disease</a> </li> <li> <a href="/disease-treatments/parkinsons-disease">Parkinson's Disease</a> </li> <li> <a href="/disease-treatments/sickle-cell-disease">Sickle Cell Disease</a> </li> <li> <a href="/disease-treatments/sma">Spinal Muscular Atrophy</a> </li> <li> <a href="/disease-treatments/wilson-disease">Wilson Disease</a> </li> <li> <a href="/disease-treatments/xlmtm">X-Linked Myotubular Myopathy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/patient-journey">Patient Journey</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/patient-journey/identifying-a-genetic-disease">Identifying a Genetic Disease</a> </li> <li> <a href="/patient-journey/next-steps-with-a-diagnosis">Next Steps With a Diagnosis</a> </li> <li> <a href="/patient-journey/patient-focused-policy-positions">Patient-Focused Policy Positions</a> </li> <li> <a href="/patient-journey/stimulating-research">Stimulating Research</a> </li> <li> <a href="/patient-journey/considering-a-clinical-trial">Considering a Clinical Trial</a> </li> <li> <a href="/patient-journey/ethical-issues-germline-gene-editing">Ethical Issues: Germline Gene Editing</a> </li> <li> <a href="/patient-journey/ethical-issues-illegitimate-clinical-trials">Ethical Issues: Unproven Stem Cell Products</a> </li> <li> <a href="/patient-journey/gene-therapy-centers">Gene Therapy Centers</a> </li> <li> <a href="/patient-journey/clinical-trials-finder">Clinical Trials Finder</a> </li> <li> <a href="/patient-journey/on-demand">On Demand Webinars</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/newsletter">Newsletter</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/newsletter/subscribe-to-the-patient-press">Subscribe to The Patient Press</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/quick-takes">Quick Takes</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/quick-takes/focused-ultrasound-in-cell-and-gene-therapies">Focused Ultrasound in CGTs</a> </li> <li> <a href="/quick-takes/access-to-approved-cell-and-gene-therapies">Access to Approved CGTs</a> </li> <li> <a href="/quick-takes/informed-consent">Informed Consent</a> </li> <li> <a href="/quick-takes/state-of-the-field-cgt-highlights-and-approvals-20">State of the Field: CGT Highlights and Approvals of 2023</a> </li> <li> <a href="/quick-takes/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/events">Events</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a> </li> <li> <a href="/events/annual-meeting-patient-advocate-offerings">Annual Meeting-Patient Advocate Offerings</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/about-asgct">About</a> <button type="button"><span class="is-sr-only">toggle subnavigation</span></button> <ul> <li> <a href="/about-asgct/overview">Overview</a> </li> <li> <a href="/about-asgct/about-asgct">About ASGCT</a> </li> <li> <a href="/about-asgct/news">ASGCT News</a> </li> <li> <a href="/about-asgct/privacy-policy">Privacy Policy</a> </li> </ul> <div class="navDropToggle"></div> </li> <li> <a href="/support">Support</a> </li> </ul> <a href="asgct.org" class="px-1 is-external is-hidden-desktop">ASGCT.org</a> </div> </nav> </header> <main class="c-main" id="content"> <section class="c-breadcrumbs"> <div class="container"> <span><a href="/">Home</a> > </span> <a href="/patient-journey" title="Patient Journey" class="CMSBreadCrumbsLink">Patient Journey</a> > <span class="CMSBreadCrumbsCurrentItem">Stimulating Research</span> </div> </section> <section class="section"> <div class="container"> <div class="columns"> <div class="column is-8"> <h1 class="is-like-h2">Stimulating Research</h1> </div> </div> <div class="columns"> <div class="column is-8"> <div class="c-leader"> </div> <div class="content mb-6"> <p>At any given time, there are thousands of active clinical trials—all testing treatments that someday may help slow, stop or even cure diseases. And even if there isn’t an existing trial for a specific disease, someday there could be. The development of a treatment has to start somewhere, and it doesn’t have to be an initiative from a large pharmaceutical company. It can often be grassroots support from a patient organization. There are a variety of required steps in the research and development of any new therapy, including a gene therapy, along with a variety of important resources that are needed as well.</p> <h2>Watch: Research Readiness for Rare Diseases</h2> <p>Check out this symposium from the 2024 Annual Meeting organized by ASGCT's Patient Outreach Committee on research readiness.</p> <p><iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen="" frameborder="0" height="315" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/3_mr6SqdBJs?si=9MF6TnP4OeiV5TWN" title="YouTube video player" width="560"></iframe></p> <h2>Preclinical and Clinical Trials</h2> <p>All new therapies being developed are tested in laboratory animals or cell-based models in preclinical studies before being considered safe enough to proceed into studies of patients. There are often many failures before a success is reached, meaning that early studies may prove ineffective or unsafe and therefore cannot move forward.</p> <p><img alt="" src="https://asgct.org/getmedia/419f9882-214d-41ae-b7f3-a2df528c10c3/GT-3-Illustrations-03.aspx?width=400&height=322" style="width: 400px; height: 322px; float: right; margin: 5px 10px;" />Research teams take every effort to use as few animals as possible during preclinical studies, and work hard to ensure that they are treated humanely. When possible, researchers use computer or cell-based models instead of animals.  In preclinical studies, researchers investigate how a treatment is absorbed in the blood, how it is broken down chemically in the body, whether it can become toxic to the body, and other characteristics. These tests help show if the drug has any toxic side effects and establish approximate safe dose ranges for humans. If the results are positive, the treatment will transition from a preclinical study into a clinical trial with human patients.</p> <p>The <a href="/clinical-trials/clinical-trials-process">clinical trials process</a> is a learning process with <a href="https://courageousparentsnetwork.org/videos/managing-expectations-trials-are-a-learning-process-and-timelines-change/" target="_blank">timelines that can often change</a>, sometimes taking eight years or more. This is because of different factors that go into each trial, including study planning, authorization to run a trial, funding, research materials, ethics reviews and more. Researchers need to first establish safe doses for patients and ensure that the data from the trial outcomes and follow up of patients is carefully analyzed. Other factors that will be looked at include number and frequency of doses, how long the effect is, if the treatment varies between patients, and any risks for specific patient groups.</p> <h2>Starting a Study</h2> <p>Clinical trials are typically sponsored and funded by pharmaceutical companies, academic institutions, federal agencies or patient organizations. Doctors and other healthcare providers can also sponsor clinical research. Each clinical study is led by a principal investigator, who is usually a medical doctor, and a research team of doctors, nurses and other healthcare professionals and researchers to support the safe and efficient running of the trial.</p> <p><img alt="" src="https://asgct.org/getmedia/33b402ab-614f-43a7-937d-08108a903353/GT-3-Illustrations-01.aspx?width=225&height=185" style="width: 225px; height: 185px; float: left; margin: 5px 10px;" />It can be challenging to find a clinician scientist who treats and studies a rare genetic disease and has the time and expertise to run a clinical study in small patient populations. Finding a research team, adequate funding, or even collecting enough initial data to properly plan a study can prove to be a daunting task. Clinical trials needed for FDA approvals of new drugs have a median cost of<a href="https://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html" target="_blank"> $19 million,</a> and these studies come with lengthy time commitments for all professionals involved.</p> <p>Here are some resources to check out:</p> <ul> <li> <p><span style="font-size:18px;">Reference our list of U.S. <a data-auth="NotApplicable" data-linkindex="2" href="/gene-therapy-101/gene-therapy-centers" rel="noopener noreferrer" target="_blank">Gene Therapy Centers</a> if you are seeking gene therapy research for a rare disease.</span></p> </li> <li> <p><span style="font-size:18px;">The National Center for Advancing Translational Sciences (NCATS) has a <a data-auth="NotApplicable" data-linkindex="3" href="https://toolkit.ncats.nih.gov/" rel="noopener noreferrer" target="_blank">toolkit </a>for Patient-Focused Therapy Development to provide information and resources to help patient groups support the process of developing a treatment or cure for their disease(s).</span></p> </li> </ul> <h2>The Role of Patients and Advocates</h2> <p>Individual patients can take action on their own, but the reach, connections and collective power of a patient organization has an advantage in stimulating drug development. With this in mind, stimulating research can actually start with strengthening an existing patient organization (recruiting new members, fundraising, attending events) or even creating a new one if there is a need. The stronger a patient community becomes, the more effective they will be in helping a treatment through stages of drug development.</p> <p><strong>Data Collection</strong> is a way patients and advocates can help push clinical trials forward. The data may come in many different forms, but the goal is to gather or strengthen information about the disease for researchers to reference when planning a study. Relevant information may include: health data, demographics, lifestyle, family history, genetic data, clinical records, or physical samples.</p> <p><strong><img alt="" src="https://asgct.org/getmedia/a7772211-9717-47d6-ac99-add93f9cb978/GT-3-Illustrations-02.aspx?width=250&height=232" style="width: 250px; height: 232px; float: right; margin: 5px 10px;" />Natural history studies</strong> are critical to informing a future clinical trial, drug development, and patient recruiting for these treatments. These are studies that collect information about how a disease progresses in the absence of treatment, which is often in the form of tissue donations from living or deceased patients. This is a way people with a disease can contribute to the research of that disease, even if a clinical trial isn’t available during their lifetime. This data is immensely valuable to researchers, as the information is typically unavailable or incomplete for most rare diseases.</p> <p><strong>Funding</strong> is also important to help get research started and keep momentum. Patient organizations can solicit corporate and federal donations, create fundraising campaigns, host events and apply for grants. The cost of getting a trial started varies, but can start at a few hundred thousand dollars. This is the cost of the required research to begin the trial process. Having a well-connected community helps with fundraising, advocacy for the disease and helping raise awareness  in the general public. This visibility then can lead to support, additional fundraising, legislation and other actionable benefits.</p> <p><strong>Recruiting volunteers </strong>is another way to help once a clinical trial is active and recruiting (in need of participants). As the different phases of clinical trials progress, researchers need increasing amounts of eligible patients to participate. Finding the appropriate number of patients with a rare genetic disorder that fit the inclusion criteria for a safe study can be challenging for researchers. This can cause the research and development of a drug to stall even before it reaches the clinical trial phase. For studies being conducted in a limited number of locations, patient organizations may also be able to help pay for patient travel to study centers.</p> <p><strong>Setting realistic expectations</strong> is important, as is understanding that the road to develop a treatment is long, complicated, costly, and are ultimately experimental, so nothing is guaranteed. When research is unsuccessful, it doesn’t mean there is no hope for a particular treatment, but rather something unexpected may have happened or there wasn’t enough impact shown in a certain period of time. When research is successful, it can potentially change the lives of patients and their families forever.<br />  </p> <hr /> <h3>A Mother’s Journey Stimulating Research</h3> <p><i>Written by Sharon King, Founder of Taylor’s Tale</i></p> <p>We founded Taylor’s Tale in 2007 when my daughter was diagnosed with CLN1 disease, a form of <a href="/disease-treatments/batten">Batten disease</a>. Though a national organization already existed to support families and foster scientific progress, we felt starting our own public charity gave us—and children like Taylor—the best opportunity for a successful effort.</p> <p>Taylor’s Tale began with an almost singular focus: to fund treatment development for CLN1 disease. We have helped advance important work in enzyme replacement therapy and small molecule therapy, but the most promising has been an innovative gene therapy research program for Batten disease that had its beginning at the University of North Carolina at Chapel Hill Gene Therapy Center in 2013.</p> <p>I met Dr. Steven Gray in late 2011 at a Batten disease workshop in Bethesda, Maryland. Dr. Gray presented his work in Giant Axonal Neuropathy (GAN) and the potential for a similar study in Batten. The GAN study could serve as a blueprint for the work ahead, possibly creating greater efficiencies in time and cost. I was excited for the opportunity to work with a talented and dedicated young investigator who shared my end goal—getting to the clinic.</p> <blockquote> <p> <div class="bodyQuote"> <div class="bodyQuoteOpen"><span></span></div> <div class="bodyQuoteContent"> <p>“We’ll have to be relentless, you know. Nothing worth having is ever easy.”</p> <div class="bodyQuoteCredit">Steven Gray, Ph.D.</div> </div> <div class="bodyQuoteClose"><span></span></div> </div> </p> </blockquote> <p>Taylor’s Tale spent the next year learning more about gene therapy, following GAN’s progress and raising funds to support a CLN1 disease project in Dr. Gray’s lab. I reconnected with Dr. Gray at the International NCL Congress in London during the spring of 2012 and realized it was time to move a project forward. Taylor’s Tale spearheaded the alliance of several patient-driven organizations to fund parallel studies in CLN1 and CLN2 disease, and we announced our support of around $350-400K on Rare Disease Day 2013. The original grant was for a period of two years, and at the end of that time, the CLN1 data was very promising. Taylor’s Tale followed on with additional short-term funding until a new partner could be identified to complete the pre-clinical study.</p> <p>In 2016, a clinical-stage biopharmaceutical company added Dr. Gray’s promising preclinical work to its pipeline. Since then, the company has been cleared to enter a Phase 1/2 clinical trial, following acceptance of an investigational new drug application in 2019.</p> <p>Early on in our partnership, Dr. Gray told me, “We’ll have to be relentless, you know. Nothing worth having is ever easy.” It was good advice for any patient-driven organization helping to move forward a novel therapy.</p> <hr /> <p> </p> </div> </div> <div class="column is-4 pl-4"> <div class="c-nav-local-wrap"> <div class="asideBox"> <h3> Related Pages</h3> <hr class="is-secondary" /> <ul class="c-nav-local-list"> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/identifying-a-genetic-disease">Identifying a Genetic Disease</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/next-steps-with-a-diagnosis">Next Steps With a Diagnosis</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/patient-focused-policy-positions">Patient-Focused Policy Positions</a> </li> <li class="c-nav-local-item is-active"><a class="c-nav-local-link" href="/patient-journey/stimulating-research">Stimulating Research</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/considering-a-clinical-trial">Considering a Clinical Trial</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/ethical-issues-germline-gene-editing">Ethical Issues: Germline Gene Editing</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/ethical-issues-illegitimate-clinical-trials">Ethical Issues: Unproven Stem Cell Products</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/gene-therapy-centers">Gene Therapy Centers</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/clinical-trials-finder">Clinical Trials Finder</a> </li> <li class="c-nav-local-item"><a class="c-nav-local-link" href="/patient-journey/on-demand">On Demand Webinars</a> </li> </ul> </div> </div> </div> </div> </div> <div class="lastUpdatedTag"> <p>Last Updated: 09/25/2024</p> </div> </section> </main> <footer class="c-footer"> <div class="c-footer-primary"> <section class="section"> <div class="container"> <div class="columns"> <div class="column c-footer-section"> <p><img alt="" src="/PatientEducation/media/PatientEducation/logo_white.png" /></p> <p>20800 Swenson Dr., Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="column is-two-fifths c-footer-section"> <ul class="c-utility-list"> <li><a href="#">Gene Therapy 101</a></li> <li><a href="#">Disease Treatments</a></li> <li><a href="#">Clinical Trials</a></li> <li><a href="/patient-journey">Patient Journey</a></li> <li><a href="/about-asgct">About</a></li> <li><a href="/support">Support</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="column c-footer-section"> <h3 class="mb-3">Connect with ASGCT</h3> <p class="mb-0"><span>Phone: 414</span>.278.1341</p> <p><a href="mailto:info@asgct.org">info@asgct.org</a></p> <p> <div class="c-social"> <ul class="c-social-list"> <li class="c-social-item"><a href="https://twitter.com/ASGCTherapy" target="_blank" class="c-social-link twitter"><span class="is-sr-only">Twitter</span></a></li> <li class="c-social-item"><a href="https://www.facebook.com/ASGCTherapy" target="_blank" class="c-social-link facebook"><span class="is-sr-only">Facebook</span></a></li> <li class="c-social-item"><a href="https://www.instagram.com/asgctherapy" target="_blank" class="c-social-link instagram"><span class="is-sr-only">Instagram</span></a></li> <li class="c-social-item"><a href="https://www.linkedin.com/company/asgct" target="_blank" class="c-social-link linkedin"><span class="is-sr-only">LinkedIn</span></a></li> <li class="c-social-item"><a href="https://www.youtube.com/user/ASGCT" target="_blank" class="c-social-link youtube"><span class="is-sr-only">YouTube</span></a></li> </ul> </div> </p> </div> </div> </div> </section> </div> <div class="c-footer-secondary"> <section class="section py-4"> <div class="container"> <div class="columns"> <div class="column"> <p class="is-small">© 2024 All rights reserved. American Society of Gene & Cell Therapy.</p> <p class="is-tiny">Web design by <a href="https://www.reasononeinc.com/kentico" target="_blank">Reason One</a>. Powered by <a href="http://www.kentico.com" target="_blank">Kentico</a>.</p> </div> </div> </div> </section> </div> </footer> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/pe_assets/build/main.js" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>

CINXE.COM

Stimulating Research | ASGCT - American Society of Gene & Cell Therapy |